£53k
−35%vs Feb 2024Active13921177Private limited companyLondon
ANTIBODY DESIGN LTD
Significant control: Alejandro Ramirez (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Antibody Design Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Antibody Design Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ANTIBODY DESIGN LTD is an active private limited company (company number 13921177) incorporated on 16 February 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 28 February 2025, showing net assets of £53k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 35% on the prior period (£83k).
Peer position · net assets
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Dr. Alejandro Ramirez
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 16 February 20224 yrs ago
- Next accounts due
- 28 November 2026in 34 days
- Confirmation statement due
- 2 March 2027in 128 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Feb 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £53k | — | — | — | — | — | 2 |
| 28 February 2024 | £83k | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £53,250 at 28 February 2025
- Net assets down 25% or more on the prior period-35.5% vs prior period
- Incorporated two to five years agoIncorporated 16 February 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 128 days
- Next accounts duein 34 days
- Accounts period endNet assets £53k · micro accounts
- Accounts period endNet assets £83k · micro accounts
- Incorporated
08
Similar companies in London
- OCUS INNOVATION (UK) LIMITEDLondon · inc. Feb 2022
- WOOST LTDLondon · inc. Feb 2022
- BIOMINIONS LTDLondon · inc. Feb 2022
- QUANTICO MRI LIMITEDLondon · inc. Feb 2022
- FULL CIRCLE LABS LTDLondon · inc. Mar 2022
- LEV HAI GENETICS LTDLondon · inc. Mar 2022
All companies incorporated on 16 February 2022 · in Feb 2022.
09
Reminders for ANTIBODY DESIGN LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.